Kelley Shannon T sold MDGL
January 20, 2026 · Form 4 insider transaction
Kelley Shannon T sold 429 shares of Madrigal Pharmaceuticals, Inc. at $501.40 per share, a transaction worth $215.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
429
Price
$501.40
Total value
$215.1K
InsiderKelley Shannon T
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 20, 2026
Filing dateJanuary 20, 2026
Shares owned after8,481
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024.